Home > Insider Trading > Filing (0001127602-24-021385)

Filing Details

Accession Number:: 0001127602-24-021385
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-08-01 17:06:42
Reporting Period:: 2024-07-31

Accepted Time:: 2024-08-01 17:06:42
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
97745	Thermo Fisher Scientific Inc.	TMO	Measuring & Controlling Devices, Nec (3829)	042209186

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1216055	N Marc Casper	168 Third Avenue Waltham MA 02451	Chairman & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-07-31	10,000	$210.68	133,816	No	4	M	Direct
Common Stock	Disposition	2024-07-31	294	$612.55	133,522	No	4	S	Direct
Common Stock	Disposition	2024-07-31	1,552	$613.52	131,970	No	4	S	Direct
Common Stock	Disposition	2024-07-31	1,036	$614.87	130,934	No	4	S	Direct
Common Stock	Disposition	2024-07-31	945	$615.81	129,989	No	4	S	Direct
Common Stock	Disposition	2024-07-31	670	$617.06	129,319	No	4	S	Direct
Common Stock	Disposition	2024-07-31	1,790	$618.18	127,529	No	4	S	Direct
Common Stock	Disposition	2024-07-31	2,497	$619.48	125,032	No	4	S	Direct
Common Stock	Disposition	2024-07-31	1,216	$620.12	123,816	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2024-07-31	10,000	$0.00	10,000	$210.68

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
65,850		2025-02-27	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	11,300	Indirect	By Alison Casper 2020 Irrevocable Trust
Common Stock	43,608	Indirect	By Floral Park Associates, Inc.
Common Stock	5,000	Indirect	By MNC 2020 Irrevocable Trust

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $612.40 to $612.85, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8) and (9) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $613.07 to $613.98, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $614.21 to $615.17, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $615.43 to $616.20, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $616.69 to $617.65, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $617.84 to $618.79, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $618.84 to $619.78, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $619.88 to $620.24, inclusive.
The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
The option vested in four equal installments on February 27, 2019, 2020, 2021, and 2022.